REGENXBIO Inc. (NASDAQ:RGNX) Q3 2024 Earnings Call Transcript November 6, 2024
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.17 EPS, expectations were $-1.16.
Operator: Welcome everyone to the Q3 2024 REGENXBIO Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. At this time, I’d like to turn the conference over to Patrick Christmas, Chief Legal Officer of REGENXBIO. Please go ahead.
Patrick Christmas: Good...
